-
Wistar Institute researchers exploring a universal influenza vaccine that would eliminate annual flu shots
PHILADELPHIA — A team of scientists at The Wistar Institute has determined that it might be possible to stimulate the immune system against multiple strains of influenza virus by sequentially vaccinating individuals with distinct influenza strains isolated over the last century, researchers announced Monday.
Their results also suggest that world health experts might need to re-evaluate standard tests used for surveillance of novel influenza strains. Their findings are published in the Journal of Experimental Medicine.
-
Mylan launches generic version of Trilipix
PITTSBURGH — Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.
Mylan announced the launch of generic fenofibric acid delayed-release capsules in the 45-mg and 135-mg strengths.
The drug is a generic version of Abbott's Trilipix, designed for use in combination with statin drugs and diet to reduce triglycerides and increase high-density lipoprotein or "good" cholesterol.
Various versions of the drug had sales of about $553.6 million during the 12-month period that ended in March, according to IMS Health.